Teasing apart causation from correlation is vital if we are to understand whether the gut microbiome changes the risk of cancer or whether cancer changes the gut microbiome
After a very difficult year for cancer clinical trials, we look to the future and ask what positive lessons can be learnt
Payam Gammage believes understanding the mutations in mtDNA could reveal indicators of cancer prognosis and a new focus for therapeutics.
Our sandpit workshops bring together researchers from different disciplines to develop research ideas for the early detection of cancer.
Cancer Research UK scientists in collaboration with Roche have developed a new antibody that can target CD25 and harness the immune system against cancer.
In the search for new treatments for high-grade serous ovarian carcinoma, one Cancer Research-UK funded team built a living biobank.
We’re supporting new research exploring aneuploidy as a driver of children’s and young people’s cancer and a target for novel therapies.
We spoke to three Women of Influence participants – a mentor and her two mentees – about their experiences of being involved in the initiative.
We’re changing our peer review process for grants, reducing the emphasis on written peer reviews and instead focusing on expert review panels.